Genomics BioSci & Tech Co., Ltd. (4195) Stock Forecast & Analysis

Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Genomics BioSci & Tech Co., Ltd. (4195:TWSE), powered by AI.

Current Price
$15.70
Sector
Healthcare
What is the Genomics BioSci & Tech Co., Ltd. stock price forecast?

Genomics BioSci & Tech Co., Ltd. is currently trading at $15.70. View real-time AI analysis on Alpha Lenz.

What is Genomics BioSci & Tech Co., Ltd. insider trading activity?

View the latest insider trading data for Genomics BioSci & Tech Co., Ltd. on Alpha Lenz.

What is Genomics BioSci & Tech Co., Ltd.'s P/E ratio?

View Genomics BioSci & Tech Co., Ltd.'s valuation metrics on Alpha Lenz.

Genomics BioSci & Tech Co., Ltd.

TWSE · 4195
NT$15.70+0.00(+0.00%)
Ask about Genomics BioSci & Tech Co., Ltd.'s future dividend policy...
Alpha Chat Insight

Genomics BioSci & Tech Co., Ltd.'s ROE is -7.4%. Explore profitability and growth together.

Ask for details

Company Overview

Genomics BioSci & Tech Co., Ltd. is a biotechnology company specializing in the manufacture, research, and development of genomic solutions and biotechnological services. Established in 2001 and headquartered in New Taipei City, Taiwan, the company leverages advanced DNA sequencing technologies, including first, second, and third-generation sequencing platforms, to provide comprehensive laboratory and bioinformatics services. Its offerings span DNA and gene sequencing, oligonucleotide and peptide synthesis, genomic and proteomic analysis, as well as antibody preparation and mutation detection. Genomics BioSci & Tech Co., Ltd. also delivers contract development and manufacturing services (CDMO), catering to the pharmaceutical, vaccine adjuvant, cellular, and gene therapy industries. A significant player in Taiwan's health technology sector, the company serves research institutions, healthcare providers, and commercial clients, supporting scientific innovation and the advancement of precision medicine through a robust infrastructure and experienced professional teams. Genomics BioSci & Tech Co., Ltd. holds international certifications and emphasizes quality assurance across its product and service portfolio.

SectorHealthcare
IndustryBiotechnology
0

Company Statistics

FY 2025

Profile

N/AMarket Cap
NT$708.38MRevenue
0.00Shares Out
0Employees

Margins

32.66%Gross
4.59%EBITDA
-10.53%Operating
-9.55%Pre-Tax
-9.55%Net

Valuation

N/AP/E
N/AP/B
N/AEV/Sales
N/AEV/EBITDA
N/AP/FCF

Growth (CAGR)

19.13%Rev 3Yr
9.83%Rev 5Yr
N/AOp Inc 3Yr
N/AOp Inc 5Yr
N/ANet Inc 3Yr
N/ANet Inc 5Yr

Returns

-4.85%ROA
-7.45%ROE
-3.79%ROIC

Financial Health

NT$138.30MCash & Cash Equivalents
NT$705.77MNet Debt
145.01%Debt/Equity
N/AInterest Cov

Frequently Asked Questions

Genomics BioSci & Tech Co., Ltd. (ticker: 4195) is a company listed on TWSE in the Healthcare sector (Biotechnology).

The current price is 15.7 with a P/E ratio of -x and P/B of -x.

ROE is -7.45% and operating margin is -10.53%. Annual revenue is $708M.

Alpha Lenz
Singapore
Treasurer Pte Ltd | License: 202346277E
9 Straits View Marina One West Tower #05-07 Singapore 018937
contact@treasurer.co.kr
©2026 Treasurer Pte Ltd. All rights reserved.
Genomics BioSci & Tech Co., Ltd. (4195) Stock Forecast 2026 $15.70 — Price, Financials & Analyst Targets | Alpha Lenz